Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

NCT03701217 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Eltrombopag
Thrombocytopenia
Acute Myeloid Leukemia

Interventions

DRUG: Eltrombopag

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]